Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PB-718 in Chinese Obese Subjects
NCT06147544Phase 2Completed
- Sponsor
- PegBio
- Start
- Jul 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of PB-718 in obesity, sponsored by PegBio. Started Jul 2023; status: completed.
02
Drugs
PB-718
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06147544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06147544.